IDEAYA Biosciences, Inc. (IDYA) › Operating IncomeIDEAYA Biosciences, Inc. (IDYA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2017: -$14.44M2018: -$36.42M2019: -$44.27M2020: -$35.34M2021: -$50.27M2022: -$62.50M2023: -$134.43M2024: -$326.98M2025: -$159.31M-$159.31M2017Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$159.31M+51.3%2024-$326.98M-143.2%2023-$134.43M-115.1%2022-$62.50M-24.3%2021-$50.27M-42.2%2020-$35.34M+20.2%2019-$44.27M-21.6%2018-$36.42M-152.2%2017-$14.44M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share